Skip to content
Forest Global Training Partners
Home Services AI Governance AI Navigators Contact Us
AI Navigators AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Hallucinations
  3. Hallucinationsin AI: How GSK is addressing a critical…

AI Hallucinations January 15, 2025 · venturebeat.com

Hallucinationsin AI: How GSK is addressing a critical problem in drug development

Hallucinationsare a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems …

Read the original at venturebeat.com ↗

Topics
Hallucinations & FabricationHealthcare
Tracked via
Google Alert “AI hallucination”

Related articles

  • TheAIAdvantage: Reimagining the Future of Drug Development - Med City News AI Risks · Dec 18, 2024
  • Actuarial AI Risk Manager (Responsible AI), GSK, London, UK AI Risks · Mar 27, 2024
  • Artificial intelligencein drug development | Nature Medicine AI Risks · Jan 20, 2025
  • AI will boost drug development in 2025 - The Economist AI Use Cases · Nov 20, 2024
  • HowAIAccelerates Clinical & Drug Development Timelines | Fierce Biotech AI Risks · Jun 30, 2024
  • How AI is Changing the Drug Development Journey - Pharmaceutical Executive AI Risks · Feb 22, 2024

AI Navigators is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact